Status:
COMPLETED
Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
Lead Sponsor:
Montefiore Medical Center
Conditions:
Acute Pain
Eligibility:
All Genders
21-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and speed of onset of 2mg intravenous hydromorphone (Dilaudid) in patients weighing at least 150 lbs presenting to the emergency department with ac...
Detailed Description
Introduction and Background: Pain is cited as the most frequent reason for visits to emergency departments (EDs) (McCaig, 2001). It can be estimated from the National Hospital Ambulatory Medical Care ...
Eligibility Criteria
Inclusion
- Age greater than 21 years
- Age less than 65 years of age
- Pain with onset within 7 days
- ED attending physician's judgment that patient's pain warrants use of morphine
- Normal mental status
Exclusion
- Prior use of methadone
- Use of other opioids or tramadol within past seven days
- Prior adverse reaction to hydromorphone.
- Chronic pain syndrome
- Alcohol intoxication
- SBP \<90 mm Hg
- Use of MAO inhibitors in past 30 days
- C02 measurement greater than 46
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
298 Patients enrolled
Trial Details
Trial ID
NCT00305110
Start Date
January 1 2006
End Date
October 1 2006
Last Update
August 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467